Cargando…

Tin-based Antitumour Drugs

Detalles Bibliográficos
Autor principal:	Gielen, Marcel
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 1994
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364889/ https://www.ncbi.nlm.nih.gov/pubmed/18476233 http://dx.doi.org/10.1155/MBD.1994.213

Ejemplares similares

Tin-Based Antitumour Drugs: New Developments
por: Gielen, Marcel
Publicado: (1995)

Synthesis, Characterization and Antitumour Activity of Di-n-Butyltin Salicyloxamate
por: Gielen, Marcel, et al.
Publicado: (1998)

Synthesis, Characterization and Antitumour Activity of Some Butyltin(IV) Cysteaminates and N,N-Dimethylcysteaminates
por: Gielen, Marcel, et al.
Publicado: (2000)

Triphenyltin Ortho-Aminophenyl- and 2-Pyridyl-Thiolates: Synthesis and In Vitro Antitumour Activity
por: Gielen, Marcel, et al.
Publicado: (1996)

Synthesis, Characterization and Antitumour Activities of Di-n-Butyl- and Dimethyltin D-(+)-Camphorates
por: Gielen, Marcel, et al.
Publicado: (1998)

Synthesis, Characterization and High In Vitro Antitumour Activity of Novel Triphenyltin Carboxylates
por: Gielen, Marcel, et al.
Publicado: (1994)

Di-n-Butyl-, Tri-n-Butyl- and Triphenyltin dl-Terebates: Synthesis, Characterization and In Vitro Antitumour Activity
por: Gielen, Marcel, et al.
Publicado: (1997)

Antitumour Drug-Radiation Interactions
por: Carmichael, J.
Publicado: (1992)

Synthesis, Characterization and In Vitro Antitumour Activity of Di-n-Butyl, Tri-n-Butyl and Triphenyltin 3,6-Dioxaheptanoates and 3,6,9-Trioxadecanoates
por: Kemmer, Martine, et al.
Publicado: (1998)

Modulation of the toxicity and antitumour activity of alkylating drugs by steroids.
por: Shepherd, R., et al.
Publicado: (1982)

Toxicity Profiles In Vivo in Mice and Antitumour Activity in Tumour-Bearing Mice of Di- and Triorganotin Compounds
por: Gielen, M., et al.
Publicado: (1998)

Synthesis, Characterization and In vitro Antitumour Activity of Novel Organotin Derivatives of 1,2- and 1,7-Dicarba-Closo-dodecaboranes
por: Gielen, Marcel, et al.
Publicado: (1995)

Antitumour activity of peroxidases.
por: Everse, K. E., et al.
Publicado: (1985)

Antitumour Antibiotics
por: Fox, B. W.
Publicado: (1979)

MDR1 causes resistance to the antitumour drug miltefosine
por: Rybczynska, M, et al.
Publicado: (2001)

The antitumour activities of statins
por: Takahashi, H.K., et al.
Publicado: (2007)

Enhancement of antitumour activity of etoposide by dihydropyridines on drug-sensitive and drug-resistant leukaemia in mice.
por: Kiue, A., et al.
Publicado: (1991)

The realisation of targeted antitumour therapy
por: Bicknell, R
Publicado: (2005)

Cimetidine enhancement of cyclophosphamide antitumour activity.
por: Dorr, R. T., et al.
Publicado: (1982)

Dynamics of an Antitumour Model with Pulsed Radioimmunotherapy
por: Wang, Gang, et al.
Publicado: (2022)

Effect of liposomally trapped antitumour drugs on a drug-resistant mouse lymphoma in vivo
por: Richardson, V. J., et al.
Publicado: (1982)

An Overview of Antitumour Activity of Polysaccharides
por: Jin, Hongzhen, et al.
Publicado: (2022)

Tin tin : the complete companion /
por: Farr, Michael

Antitumour Effects of Astaxanthin and Adonixanthin on Glioblastoma
por: Tsuji, Shohei, et al.
Publicado: (2020)

N-methylformamide: antitumour activity and metabolism in mice.
por: Gescher, A., et al.
Publicado: (1982)

Targeted antitumour therapy – future perspectives
por: Ranson, M, et al.
Publicado: (2005)

Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response
por: Gilabert-Oriol, Roger, et al.
Publicado: (2018)

Molecular basis for Poria cocos mushroom polysaccharide used as an antitumour drug in China
por: Li, Xiulian, et al.
Publicado: (2018)

The Chemistry of Antitumour Antibiotics, Vol. I
por: Fox, B. W.
Publicado: (1979)

Antitumour imidazotetrazines: past, present… and future?
por: Stevens, Malcolm F. G., et al.
Publicado: (2023)

Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice
por: Rossin, Raffaella, et al.
Publicado: (2018)

NIR-driven Smart Theranostic Nanomedicine for On-demand Drug Release and Synergistic Antitumour Therapy
por: Zhao, Pengfei, et al.
Publicado: (2015)

In Vitro Antitumour Activity of Some Triorganophosphinegold(I) Thionucleobases
por: Tiekink, Edward R. T., et al.
Publicado: (1994)

Antitumour and Immunomodulatory Effects of Cu(II) Complexes of Thiobenzyhdrazide
por: Singh, Nand K., et al.
Publicado: (2002)

Proceedings: Demonstration of the antitumour effect of in vivo macrophage activation.
por: Parr, I.
Publicado: (1974)

Antitumour imidazotetrazines, Part IX. The pharmacokinetics of mitozolomide in mice.
por: Goddard, C., et al.
Publicado: (1985)

Antitumour effect of corynebacterium parvum. Possible mode of action.
por: Baum, M., et al.
Publicado: (1976)

Synergistic Antitumour Properties of viscumTT in Alveolar Rhabdomyosarcoma
por: Stammer, Rahel Mascha, et al.
Publicado: (2017)

The In Vitro Antitumour Activity of Novel, Mitochondrial-Interactive, Gold-Based Lipophilic Cations
por: Mahepal, Sherika, et al.
Publicado: (2008)

Development of novel apoferritin formulations for antitumour benzothiazoles
por: Breen, Alastair F., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_24694enmfqm697dpf9pcfdb1ei